0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-76.37%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-60.22%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-82.23%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-82.23%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-81.32%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-80.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-80.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
4.62%
Share count expansion well above LBL.AX's 2.48%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
12.14%
Diluted share count expanding well above LBL.AX's 2.48%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-54.43%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-32.83%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-50.22%
Negative 10Y revenue/share CAGR while LBL.AX stands at 228.01%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
112.77%
5Y revenue/share CAGR above 1.5x LBL.AX's 46.12%. David Dodd would look for consistent product or market expansions fueling outperformance.
49.41%
3Y revenue/share CAGR above 1.5x LBL.AX's 25.81%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
4276.79%
10Y OCF/share CAGR above 1.5x LBL.AX's 45.65%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
457.75%
5Y OCF/share CAGR above 1.5x LBL.AX's 30.04%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
259.99%
Positive 3Y OCF/share CAGR while LBL.AX is negative. John Neff might see a big short-term edge in operational efficiency.
121.31%
Net income/share CAGR at 50-75% of LBL.AX's 196.67%. Martin Whitman might question if the firm’s product or cost base lags behind.
2783.33%
Positive 5Y CAGR while LBL.AX is negative. John Neff might view this as a strong mid-term relative advantage.
0.58%
Positive short-term CAGR while LBL.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
609.64%
5Y equity/share CAGR above 1.5x LBL.AX's 188.95%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
87.12%
3Y equity/share CAGR above 1.5x LBL.AX's 29.77%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-76.11%
Firm’s AR is declining while LBL.AX shows 32.45%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
5.31%
Inventory growth well above LBL.AX's 6.76%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.87%
Positive asset growth while LBL.AX is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.88%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-13.08%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-35.81%
We cut SG&A while LBL.AX invests at 28.87%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.